Mitchell Warren

Challenges and opportunities in developing integrated sexual and reproductive health programmes

Who pays and what pays off in sexual and reproductive health? A review of the cost and cost-effectiveness of interventions and implications for future funding and markets

The long wait for long-acting HIV prevention and treatment formulations

HIV Diagnostics and Vaccines: It Takes Two to Tango

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study

Call to action: how can the US Ending the HIV Epidemic initiative succeed?

The case for an HIV cure and how to get there

Multi-stakeholder consensus on a target product profile for an HIV cure

Voluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geography

Antiretroviral pre‐exposure prophylaxis implementation in the United States: a work in progress

Translating PrEP effectiveness into public health impact: key considerations for decision‐makers on cost‐effectiveness, price, regulatory issues, distributive justice and advocacy for access

Ethical Considerations in Determining Standard of Prevention Packages for <scp>HIV</scp> Prevention Trials: Examining <scp>P</scp><scp>r</scp><scp>EP</scp>